Potential antiarthritic agents. 2. Benzoylacetonitriles and beta-aminocinnamonitriles. 1979

D N Ridge, and J W Hanifin, and L A Harten, and B D Johnson, and J Menschik, and G Nicolau, and A E Sloboda, and D E Watts

Benzoylacetonitrile and beta-aminocinnamonitrile are shown to possess potent antiinflammatory activity in the rat adjuvant arthritis model. In a series of phenyl-substituted analogues, only o-, m-, and p-fluorobenzoylacetonitrile and m- and p-fluoro-beta-aminocinnamonitrile retained activity. Additionally, beta-amino-2- and beta-amino-3-thiopheneacrylonitrile and beta-oxo-2- and beta-oxo-3-thiophenepropionitrile exhibited similar activity. These agents are not believed to be acting via prostaglandin synthetase inhibition. The metabolic profile of benzoylacetonitrile is also described.

UI MeSH Term Description Entries
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D004890 Erythema Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes. Erythemas
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000097 Acetonitriles Compounds in which a methyl group is attached to the cyano moiety. Cyanomethane,Cyanomethanes,Ethane Nitriles,Methyl Cyanide,Methyl Cyanides,Cyanide, Methyl,Cyanides, Methyl,Nitriles, Ethane
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001169 Arthritis, Experimental ARTHRITIS that is induced in experimental animals. Immunological methods and infectious agents can be used to develop experimental arthritis models. These methods include injections of stimulators of the immune response, such as an adjuvant (ADJUVANTS, IMMUNOLOGIC) or COLLAGEN. Adjuvant Arthritis,Arthritis, Adjuvant-Induced,Arthritis, Collagen-Induced,Arthritis, Adjuvant,Collagen Arthritis,Arthritides, Collagen,Arthritis, Collagen,Collagen Arthritides,Collagen-Induced Arthritides,Collagen-Induced Arthritis
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

D N Ridge, and J W Hanifin, and L A Harten, and B D Johnson, and J Menschik, and G Nicolau, and A E Sloboda, and D E Watts
January 1992, Journal of medicinal chemistry,
D N Ridge, and J W Hanifin, and L A Harten, and B D Johnson, and J Menschik, and G Nicolau, and A E Sloboda, and D E Watts
November 1987, Seminars in arthritis and rheumatism,
D N Ridge, and J W Hanifin, and L A Harten, and B D Johnson, and J Menschik, and G Nicolau, and A E Sloboda, and D E Watts
October 1978, Journal of medicinal chemistry,
D N Ridge, and J W Hanifin, and L A Harten, and B D Johnson, and J Menschik, and G Nicolau, and A E Sloboda, and D E Watts
January 2006, Current pharmaceutical design,
D N Ridge, and J W Hanifin, and L A Harten, and B D Johnson, and J Menschik, and G Nicolau, and A E Sloboda, and D E Watts
January 1985, Annals of the New York Academy of Sciences,
D N Ridge, and J W Hanifin, and L A Harten, and B D Johnson, and J Menschik, and G Nicolau, and A E Sloboda, and D E Watts
February 1980, JAMA,
D N Ridge, and J W Hanifin, and L A Harten, and B D Johnson, and J Menschik, and G Nicolau, and A E Sloboda, and D E Watts
August 1984, Comprehensive therapy,
D N Ridge, and J W Hanifin, and L A Harten, and B D Johnson, and J Menschik, and G Nicolau, and A E Sloboda, and D E Watts
March 1986, Chemical & pharmaceutical bulletin,
D N Ridge, and J W Hanifin, and L A Harten, and B D Johnson, and J Menschik, and G Nicolau, and A E Sloboda, and D E Watts
January 2023, Journal of Ayurveda and integrative medicine,
D N Ridge, and J W Hanifin, and L A Harten, and B D Johnson, and J Menschik, and G Nicolau, and A E Sloboda, and D E Watts
January 1993, Journal of medicinal chemistry,
Copied contents to your clipboard!